SYROS PHARMACEUTICALS INC lost $5.81 per diluted share in fiscal year 2023. Over the trailing 12 months, Q4 FY2023 through Q3 FY2024, the same line adds up to a loss of $3.07 per diluted share. The table below carries 10 fiscal years, from 2014 to 2023, and the quarters SYROS PHARMACEUTICALS INC has filed alongside them.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
What was SYROS PHARMACEUTICALS INC's diluted earnings per share in fiscal year 2023?
SYROS PHARMACEUTICALS INC lost $5.81 per diluted share in fiscal year 2023.
What is SYROS PHARMACEUTICALS INC's diluted earnings per share over the last twelve months?
SYROS PHARMACEUTICALS INC (SYRS) reported a loss of $3.07 per diluted share over the trailing 12 months, Q4 FY2023 through Q3 FY2024, summed from the four most recent quarterly filings.
How has SYROS PHARMACEUTICALS INC's diluted earnings per share changed over the years?
Across the 10 fiscal years this page covers, SYROS PHARMACEUTICALS INC (SYRS) diluted earnings per share went from -$10.26 in fiscal year 2014 to -$5.81 in fiscal year 2023.
What was SYROS PHARMACEUTICALS INC's diluted earnings per share in the most recent quarter?
SYROS PHARMACEUTICALS INC (SYRS) reported -$0.16 in diluted earnings per share in Q3 2024. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what SYROS PHARMACEUTICALS INC (SYRS) reported on that line in every period on record.
